Thrombocytopenia-associated multi-organ failure after Fontan operation successfully treated with plasma exchange: A case report
Post-Fontan TAMOF managed with PLEX
DOI:
https://doi.org/10.54205/ccc.v34.276974Keywords:
Thrombocytopenia-associated multi-organ failure, Plasma exchange, Post-cardiac surgery, Cardiopulmonary bypass, Right atrial isomerismAbstract
Introduction: Thrombocytopenia-associated multi-organ failure (TAMOF) is a rare but life-threatening subtype of multiple organ dysfunction syndrome caused by thrombotic microangiopathy and decreased A Disintegrin and Metalloproteinase with a Thrombospondin type 1 motif, member 13 (ADAMTS-13) activity. Although commonly associated with sepsis, TAMOF is rarely reported after cardiac surgery.
Case Presentation: We report a 10-year-old girl with right atrial isomerism and complex congenital heart disease who developed TAMOF following extracardiac Fontan surgery. She presented with distributive shock, persistent thrombocytopenia, acute kidney injury requiring continuous renal replacement therapy, transaminitis, and encephalopathy. Laboratory findings demonstrated thrombotic microangiopathy with elevated inflammatory markers. Plasma exchange (PLEX) was initiated based on clinical suspicion and later confirmed by reduced ADAMTS-13 activity. After two PLEX sessions, the patient showed rapid improvement, including platelet recovery, resolution of neurological, hepatic, and renal dysfunction, and successful extubation.
Conclusions: Early recognition of TAMOF in post-cardiac surgery patients with unexplained thrombocytopenia and multi-organ dysfunction is critical. Prompt PLEX may result in clinical recovery and improved survival.
Downloads
References
Nguyen TC. Thrombocytopenia-associated multiple organ failure. Critical Care Clinics. 2020;36(2):379–390.
Nguyen TC, Carcillo JA. Bench-to-bedside review: thrombocytopenia-associated multiple organ failure–a newly appreciated syndrome in the critically ill. Critical Care. 2006;10:1–8.
Carcillo JA, Podd B, Aneja R, Weiss SL, Hall MW, Cornell TT, et al. Pathophysiology of pediatric multiple organ dysfunction syndrome. Pediatric Critical Care Medicine. 2017;18(3 Suppl):S32–S45.
Bernardo A, Ball C, Nolasco L, Moake JF, Dong J-F. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flow. Blood. 2004;104(1):100–106.
Studt J-D, Hovinga JAK, Antoine G, Hermann M, Rieger M, Scheiflinger F, et al. Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin. Blood. 2005;105(2):542–544.
Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, et al. Intensive plasma exchange increases ADAMTS-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Critical Care Medicine. 2008;36(10):2878–2880.
Fortenberry JD, Nguyen T, Grunwell JR, Aneja RK, Wheeler D, Hall M, et al. Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the thrombocytopenia-associated multiple organ failure network prospective experience. Critical Care Medicine. 2019;47(3):e173–e181.
Carcillo JA, Berg RA, Wessel D, Pollack M, Meert K, Hall M, et al. A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure. Pediatric Critical Care Medicine. 2019;20(12):1137–1146.
Carcillo JA, Halstead ES, Hall MW, Nguyen TC, Reeder R, Aneja R, et al. Three hypothetical inflammation pathobiology phenotypes and pediatric sepsis-induced multiple organ failure outcome. Pediatric Critical Care Medicine. 2017;18(6):513–523.
Chong M, Lopez-Magallon AJ, Saenz L, Sharma MS, Althouse AD, Morell VO, et al. Use of therapeutic plasma exchange during extracorporeal life support in critically ill cardiac children with thrombocytopenia-associated multi-organ failure. Frontiers in Pediatrics. 2017;5:254.
Vera EF, Adrian C, Lourdes M. Thrombocytopenia related to multiple organ failure (TAMOF) related to extracorporeal circulation in cardiac surgery in pediatrics. Pediatric Dimensions. 2020;5(1):1–4.
Claus RA, Bockmeyer CL, Budde U, Kentouche K, Sossdorf M, Hilberg T, et al. Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure. Thrombosis and Haemostasis. 2009;101(2):239–247.
Jacobs ML, Jacobs JP, Thibault D, Hill KD, Anderson BR, Eghtesady P, et al. Updating an empirically based tool for analyzing congenital heart surgery mortality. World Journal for Pediatric and Congenital Heart Surgery. 2021;12(2):246–281.
Prendiville TW, Barton LL, Thompson WR, Fink DL, Holmes KW. Heterotaxy syndrome: defining contemporary disease trends. Pediatric Cardiology. 2010;31:1052–1058.
Podd BS, Simon DW, Lopez S, Nowalk A, Aneja R, Carcillo JA. Rationale for adjunctive therapies for pediatric sepsis-induced multiple organ failure. Pediatric Clinics of North America. 2017;64(5):1071–1088.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 The Thai Society of Critical Care Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
